LAM
L2 Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-989
| Closed | -$460K | – | 266 |
|
|
2024
Q3 | $460K | Sell |
989
-664
| -40% | -$309K | 0.12% | 120 |
|
|
2024
Q2 | $775K | Sell |
1,653
-741
| -31% | -$347K | 0.23% | 82 |
|
|
2024
Q1 | $1M | Buy |
2,394
+673
| +39% | +$281K | 0.33% | 75 |
|
|
2023
Q4 | $700K | Buy |
1,721
+748
| +77% | +$304K | 0.29% | 78 |
|
|
2023
Q3 | $1.05M | Sell |
973
-2,176
| -69% | -$2.34M | 0.49% | 59 |
|
|
2023
Q2 | $940K | Buy |
3,149
+150
| +5% | +$44.8K | 0.46% | 60 |
|
|
2023
Q1 | $945K | Buy |
2,999
+1,515
| +102% | +$477K | 0.52% | 56 |
|
|
2022
Q4 | $429K | Hold |
1,484
| – | – | 0.27% | 82 |
|
|
2022
Q3 | $430K | Buy |
1,484
+214
| +17% | +$62K | 0.3% | 81 |
|
|
2022
Q2 | $358K | Buy |
+1,270
| New | +$358K | 0.26% | 92 |
|
|
2021
Q1 | – | Sell |
-2,904
| Closed | -$686K | – | 90 |
|
|
2020
Q4 | $686K | Buy |
2,904
+459
| +19% | +$108K | 0.47% | 55 |
|
|
2020
Q3 | $665K | Buy |
+2,445
| New | +$665K | 0.54% | 49 |
|